Latest DB-OTO Results Demonstrate Clinically Meaningful Hearing Improvements in Nearly All Children with Profound Genetic Hearing Loss in CHORD Trial
As presented at ARO, 10 of 11 children with at least one post-treatment assessment showed notable improvements in hearingSpeech and development ...
Gilead announces European Medicines Agency validation for lenacapavir
Gilead (GILD) announced that the European Medicines Agency has validated for parallel accelerated review the company’s marketing authorization ...
Le Lézard8h
IceCure Submits Filing for Regulatory Approval of its Next-Generation XSensetm Cryoablation System in Israel
IceCure Medical Ltd. ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor ...
Le Lézard16h
Telix's Illuccix® PSMA-PET Imaging Agent Approved in Norway
Telix Pharmaceuticals Limited today announces that its prostate cancer PET[1] imaging agent Illuccix® (kit for the preparation of gallium-68 gozetotide injection) has been granted marketing ...
Reuters22h
European Market Headlines | Breaking Stock Market News | Reuters
European Marketscategory Europe's STOXX 600 closes near record high; German elections in focus February 21, 2025 European Marketscategory German machinery exports decline in 2024 amid feeble ...